FindTrial
Sign In

Comparision of Dosimetry and acute toxicity among three different treatment

Comparative study of dosimetry and acute toxicity of 3d-Crt (3Dimensional Conformal Radiotherapy), IMRT (Intensity -Modulated Radiation Therapy) and Helical Tomotherapy for treatment of breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/04/024865
Enrollment
48
Registered
2020-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D- Radiation Therapy

Interventions

None listed

Sponsors

HCG Hospitals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Females with histologically proven carcinoma of breat Stage IIb-IIIc Post breast conservation surgery cases All patients treated with hypofractionation 40-42.6Gy in 15-16 fractions followed by 10-16Gy in 5-8fractions

Exclusion criteria

Exclusion criteria: Patients who have previously received radiation therapy to thorax patient with distant metastatic disease patient with recurrent disease

Design outcomes

Primary

MeasureTime frame
Dosimetry ParametersTimepoint: before and during the treatment—

Secondary

MeasureTime frame
Acute toxicityTimepoint: during the treatment, 4-6 weeks and 3 months post radiation—

Countries

India

Contacts

Public ContactDr Ayesha Mahajan

HCG Hospital

mahajanayesha12@gmail.com9685124734

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026